Risk of dementia in diabetes mellitus: a systematic review
Taken together, the in vitro study results demonstrated the potential capability of sertraline, fluoxetine, and citalopram on reversing MRP1- and MRP7-related MDR
Turmeric and curcumin: from traditional to modern medicine
Quick Answer: Headache is a recognised side effect of GLP-1 receptor agonists, classified as common (1 in 10 to 1 in 100 people) for diabetes formulations and very common (more than 1 in 10) for weight-management doses
Research-use-only context
Key search terms included GLP1 receptor agonist nutrition, tirzepatide dietary intake, GLP1 micronutrient deficiency, GLP1 lean mass loss, GLP1 food noise emotional eating, dietitian support GLP1 weight maintenance, Australian Dietary Guidelines and NHMRC Nutrient Reference Values, alongside contemporary practice pieces such as nutrition plans for GLP1 medications and dietary recommendations for managing GLP1related gastrointestinal symptoms